Transcriptional and Proteomic Analysis of Acute Kidney Injury - Trial NCT06064305
Access comprehensive clinical trial information for NCT06064305 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Muenster and is currently Not yet recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospital Muenster
Timeline & Enrollment
N/A
Sep 29, 2023
Dec 01, 2024
Primary Outcome
Correlation of transcriptional and proteomic gene regulation in tissue with clinical molecular Imaging and AKI biomarkers.
Summary
Acute kidney injury is associated with worsened outcome for critically ill patients.
 Sepsis-associated and non-septic cardiothoracic surgery associated AKI have been reported,
 nonetheless, precise pathomechanistic differences as well as detectability of transcriptional
 and proteomic changes in correlation with imaging and plasma markers are unclear.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06064305
Non-Device Trial